Focal shoulder‐elevation dystonia
Identifieur interne : 004A69 ( Main/Exploration ); précédent : 004A68; suivant : 004A70Focal shoulder‐elevation dystonia
Auteurs : R. Alan Wright [États-Unis, Nouvelle-Zélande] ; J. Eric Ahlskog [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2000-07.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adolescent, Adult, Botulinum Toxins, Type A (administration & dosage), Botulinum toxin, Dystonia, Dystonic Disorders (diagnosis), Dystonic Disorders (drug therapy), Dystonic Disorders (etiology), Female, Focal lesion, Human, Humans, Hypertrophy, Injections, Intramuscular, Male, Middle Aged, Motion, Muscle, Skeletal (drug effects), Muscle, Skeletal (pathology), Post‐traumatic movement disorder, Risk Factors, Shoulder, Symptomatology.
- MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A.
- diagnosis : Dystonic Disorders.
- drug effects : Muscle, Skeletal.
- drug therapy : Dystonic Disorders.
- etiology : Dystonic Disorders.
- pathology : Muscle, Skeletal.
- Adolescent, Adult, Female, Humans, Hypertrophy, Injections, Intramuscular, Male, Middle Aged, Risk Factors, Shoulder.
Abstract
We describe 13 cases of isolated focal dystonia of the shoulder with dystonic elevation but without clinically obvious cervical dystonia. All had significant trapezius muscle hypertrophy and limitation of shoulder movement causing substantial morbidity. In nine, this developed in the immediate aftermath of shoulder region trauma, most often a motor vehicle accident; clinically significant head trauma was not a factor. In two other cases this developed in the context of chronic heavy labor (suggesting possible overuse) and in one other it developed concurrent with the symptoms of discogenic cervical (C6‐7) radiculopathy. In the one remaining case, no precipitating factors were identified. Preexisting risk factors for dystonia, such as dopamine antagonist drug use, family history of dystonia, or prior brain injury, were not identified in these patients. Administration of medications used to treat dystonia was unsuccessful but botulinum toxin therapy was beneficial in all six treated cases.
Url:
DOI: 10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002C91
- to stream Istex, to step Curation: 002C91
- to stream Istex, to step Checkpoint: 003269
- to stream Main, to step Merge: 007366
- to stream PascalFrancis, to step Corpus: 002B86
- to stream PascalFrancis, to step Curation: 000135
- to stream PascalFrancis, to step Checkpoint: 002C03
- to stream Main, to step Merge: 007595
- to stream PubMed, to step Corpus: 003F42
- to stream PubMed, to step Curation: 003F42
- to stream PubMed, to step Checkpoint: 003F81
- to stream Ncbi, to step Merge: 000309
- to stream Ncbi, to step Curation: 000309
- to stream Ncbi, to step Checkpoint: 000309
- to stream Main, to step Merge: 007124
- to stream Main, to step Curation: 004A69
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Focal shoulder‐elevation dystonia</title><author><name sortKey="Wright, R Alan" sort="Wright, R Alan" uniqKey="Wright R" first="R. Alan" last="Wright">R. Alan Wright</name></author><author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1E9F96A3C7ED7A5D04232B432BA93F67117DA5D7</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4</idno><idno type="url">https://api.istex.fr/document/1E9F96A3C7ED7A5D04232B432BA93F67117DA5D7/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002C91</idno><idno type="wicri:Area/Istex/Curation">002C91</idno><idno type="wicri:Area/Istex/Checkpoint">003269</idno><idno type="wicri:doubleKey">0885-3185:2000:Wright R:focal:shoulder:elevation</idno><idno type="wicri:Area/Main/Merge">007366</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:00-0394877</idno><idno type="wicri:Area/PascalFrancis/Corpus">002B86</idno><idno type="wicri:Area/PascalFrancis/Curation">000135</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002C03</idno><idno type="wicri:doubleKey">0885-3185:2000:Wright R:focal:shoulder:elevation</idno><idno type="wicri:Area/Main/Merge">007595</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:10928583</idno><idno type="wicri:Area/PubMed/Corpus">003F42</idno><idno type="wicri:Area/PubMed/Curation">003F42</idno><idno type="wicri:Area/PubMed/Checkpoint">003F81</idno><idno type="wicri:Area/Ncbi/Merge">000309</idno><idno type="wicri:Area/Ncbi/Curation">000309</idno><idno type="wicri:Area/Ncbi/Checkpoint">000309</idno><idno type="wicri:doubleKey">0885-3185:2000:Wright R:focal:shoulder:elevation</idno><idno type="wicri:Area/Main/Merge">007124</idno><idno type="wicri:Area/Main/Curation">004A69</idno><idno type="wicri:Area/Main/Exploration">004A69</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Focal shoulder‐elevation dystonia</title><author><name sortKey="Wright, R Alan" sort="Wright, R Alan" uniqKey="Wright R" first="R. Alan" last="Wright">R. Alan Wright</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Current Address: University of Otago Medical School, Dunedin</wicri:regionArea><wicri:noRegion>Dunedin</wicri:noRegion></affiliation></author><author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2000-07">2000-07</date><biblScope unit="vol">15</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="709">709</biblScope><biblScope unit="page" to="713">713</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">1E9F96A3C7ED7A5D04232B432BA93F67117DA5D7</idno><idno type="DOI">10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4</idno><idno type="ArticleID">MDS1017</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Botulinum Toxins, Type A (administration & dosage)</term><term>Botulinum toxin</term><term>Dystonia</term><term>Dystonic Disorders (diagnosis)</term><term>Dystonic Disorders (drug therapy)</term><term>Dystonic Disorders (etiology)</term><term>Female</term><term>Focal lesion</term><term>Human</term><term>Humans</term><term>Hypertrophy</term><term>Injections, Intramuscular</term><term>Male</term><term>Middle Aged</term><term>Motion</term><term>Muscle, Skeletal (drug effects)</term><term>Muscle, Skeletal (pathology)</term><term>Post‐traumatic movement disorder</term><term>Risk Factors</term><term>Shoulder</term><term>Symptomatology</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dystonic Disorders</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Muscle, Skeletal</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonic Disorders</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dystonic Disorders</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Muscle, Skeletal</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Female</term><term>Humans</term><term>Hypertrophy</term><term>Injections, Intramuscular</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Shoulder</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term><term>Epaule</term><term>Homme</term><term>Lésion focale</term><term>Mouvement</term><term>Symptomatologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe 13 cases of isolated focal dystonia of the shoulder with dystonic elevation but without clinically obvious cervical dystonia. All had significant trapezius muscle hypertrophy and limitation of shoulder movement causing substantial morbidity. In nine, this developed in the immediate aftermath of shoulder region trauma, most often a motor vehicle accident; clinically significant head trauma was not a factor. In two other cases this developed in the context of chronic heavy labor (suggesting possible overuse) and in one other it developed concurrent with the symptoms of discogenic cervical (C6‐7) radiculopathy. In the one remaining case, no precipitating factors were identified. Preexisting risk factors for dystonia, such as dopamine antagonist drug use, family history of dystonia, or prior brain injury, were not identified in these patients. Administration of medications used to treat dystonia was unsuccessful but botulinum toxin therapy was beneficial in all six treated cases.</div></front></TEI><affiliations><list><country><li>Nouvelle-Zélande</li><li>États-Unis</li></country><region><li>Minnesota</li></region></list><tree><country name="États-Unis"><region name="Minnesota"><name sortKey="Wright, R Alan" sort="Wright, R Alan" uniqKey="Wright R" first="R. Alan" last="Wright">R. Alan Wright</name></region><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name></country><country name="Nouvelle-Zélande"><noRegion><name sortKey="Wright, R Alan" sort="Wright, R Alan" uniqKey="Wright R" first="R. Alan" last="Wright">R. Alan Wright</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1E9F96A3C7ED7A5D04232B432BA93F67117DA5D7
|texte= Focal shoulder‐elevation dystonia
}}
| This area was generated with Dilib version V0.6.23. |  |